Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 42

Trial Status

Completed4
Recruiting1
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT07588568Phase 2Recruiting
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
EoEEosinophilic EsophagitisEosinophilic Esophagitis (EoE)
PrincipalinvestigatorStart date: 2026-09-30
NCT06352073Phase 4Active Not Recruiting
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
EoEEosinophilic Esophagitis
PrincipalinvestigatorStart date: 2024-05-16
NCT05543512Not ApplicableCompleted
The Immune Directed Individualized Elimination Therapy (iDIET) Study
EoEEosinophilic Esophagitis
PrincipalinvestigatorStart date: 2022-10-24
NCT02019758Phase 4Completed
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Eosinophilic Esophagitis
PrincipalinvestigatorStart date: 2015-01-01
NCT01988285Completed
Risk Factors and Biomarkers for Diagnosis and Treatment of EoE
Eosinophilic Esophagitis
PrincipalinvestigatorStart date: 2011-07-28
NCT00961233Not ApplicableCompleted
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
Eosinophilic Esophagitis
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of North Carolina, Chapel Hill

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Karthik Ravi, MD

Mayo Clinic

Related
8 trials

Shared therapeutic areas:

Eosinophilic EsophagitisEosinophilic Esophagitis (EoE)

Worked with same sponsors:

Mayo Clinic
Similarity Score20%

Marc E Rothenberg, MD, PhD

Children's Hospital Medical Center, Cincinnati

Related
5 trials

Shared therapeutic areas:

Eosinophilic EsophagitisEosinophilic Esophagitis (EoE)

Worked with same sponsors:

AstraZenecaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Similarity Score20%

Jonathan M Spergel, MD, PhD

Children's Hospital of Philadelphia

Related
4 trials

Shared therapeutic areas:

Eosinophilic EsophagitisEosinophilic Esophagitis (EoE)
Similarity Score20%

Andrew W Lee, MD

Vice President, Clinical Research

Related
4 trials

Shared therapeutic areas:

Eosinophilic EsophagitisEosinophilic Esophagitis (EoE)
Similarity Score20%

Joseph Murray, MD

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Eosinophilic Esophagitis

Worked with same sponsors:

Mayo ClinicNational Institutes of Health (NIH)
Similarity Score10%

Guillermo Tearney, MD, PhD

Massachusetts General Hospital

Related
10 trials

Shared therapeutic areas:

Eosinophilic Esophagitis

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score10%

David Katzka, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Eosinophilic Esophagitis

Worked with same sponsors:

Mayo Clinic
Similarity Score10%

Michael L Kochman, MD

University of Pennsylvania

Related
3 trials

Shared therapeutic areas:

Eosinophilic Esophagitis
Similarity Score10%

Sameer Mathur, MD/PhD

UW Madison

Related
2 trials

Shared therapeutic areas:

Eosinophilic Esophagitis

Worked with same sponsors:

National Institutes of Health (NIH)
Similarity Score10%

Vinay Chandrasekhara, MD

University of Pennsylvania

Related
2 trials

Shared therapeutic areas:

Eosinophilic Esophagitis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT07588568Phase 2PrincipalInvestigator

A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

EoEEosinophilic EsophagitisEosinophilic Esophagitis (EoE)
Recruiting
NCT06352073Phase 4PrincipalInvestigator

Dupilumab for Eosinophilic Esophagitis With Severe Strictures

EoEEosinophilic Esophagitis
Active Not Recruiting
NCT05543512Not ApplicablePrincipalInvestigator

The Immune Directed Individualized Elimination Therapy (iDIET) Study

EoEEosinophilic Esophagitis
Completed
NCT02019758Phase 4PrincipalInvestigator

Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis

Eosinophilic Esophagitis
Completed
NCT01988285PrincipalInvestigator

Risk Factors and Biomarkers for Diagnosis and Treatment of EoE

Eosinophilic Esophagitis
Completed
NCT00961233Not ApplicablePrincipalInvestigator

Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)

Eosinophilic Esophagitis
Completed

All 6 trials loaded